ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 371777 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 371777; 2) Community: the network communities that were significantly associated with the response to NSC 371777; 3) Molecule: the relationships between components within communities and NSC 371777; 4) MDR: the compounds that were significantly associated with the NSC 371777.

NSC Compound Enrichment Correlation
NSC 18805 .gamma.-Thujaplicine 0.0297837393005856 0.12708349
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0297837393005856 0.16995114
NSC 300289 Pinafide 0.0297837393005856 0.18621854
NSC 303812 Aphidicoline glycinate 0.0297837393005856 0.22897741
NSC 303861 L-Cysteine analog 0.0297837393005856 0.18505323
NSC 33570 Null 0.0297837393005856 0.43457395
NSC 339137 PHYSALOLACTONE 0.0297837393005856 0.3437833
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.31256432
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0297837393005856 0.13038712
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.18331951
Total:126  Current:86    [First] [Prev] [Next] [Last]